Würth, R., Donato, E., Michel, L. L., Saini, M., Becker, L., Cheytan, T., . . . Trumpp, A. (2025). Circulating tumor cell plasticity determines breast cancer therapy resistance via neuregulin 1–HER3 signaling. Nature Cancer, 6(1), 67. https://doi.org/10.1038/s43018-024-00882-2
Chicago Style (17th ed.) CitationWürth, Roberto, et al. "Circulating Tumor Cell Plasticity Determines Breast Cancer Therapy Resistance via Neuregulin 1–HER3 Signaling." Nature Cancer 6, no. 1 (2025): 67. https://doi.org/10.1038/s43018-024-00882-2.
MLA (9th ed.) CitationWürth, Roberto, et al. "Circulating Tumor Cell Plasticity Determines Breast Cancer Therapy Resistance via Neuregulin 1–HER3 Signaling." Nature Cancer, vol. 6, no. 1, 2025, p. 67, https://doi.org/10.1038/s43018-024-00882-2.